{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:42:49Z","timestamp":1790700169328,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"BMBF\/T\u00dcBITAK IntenC Programme","award":["110S297"],"award-info":[{"award-number":["110S297"]}]},{"name":"Istanbul University Research Fund","award":["BYP-49883"],"award-info":[{"award-number":["BYP-49883"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.clim.2016.05.003","type":"journal-article","created":{"date-parts":[[2016,5,12]],"date-time":"2016-05-12T14:10:00Z","timestamp":1463062200000},"page":"81-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Genetic heterogeneity within the HLA region in three distinct clinical subgroups of myasthenia gravis"],"prefix":"10.1016","volume":"166-167","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6903-7173","authenticated-orcid":false,"given":"G\u00fcher","family":"Saruhan-Direskeneli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vuslat","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hacer","family":"Durmus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Adler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Alahgholi-Hajibehzad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fikret","family":"Aysal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibel P.","family":"Yent\u00fcr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Ali","family":"Akalin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oner","family":"Dogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Marx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yesim","family":"G\u00fclsen-Parman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piraye","family":"Oflazer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feza","family":"Deymeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr H.","family":"Sawalha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2016.05.003_bb0005","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jaut.2013.12.011","article-title":"Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms","volume":"52","author":"Berrih-Aknin","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2016.05.003_bb0010","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/brain\/103.3.579","article-title":"Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis","volume":"103","author":"Compston","year":"1980","journal-title":"Brain"},{"key":"10.1016\/j.clim.2016.05.003_bb0015","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1474-4422(09)70063-8","article-title":"Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity","volume":"8","author":"Meriggioli","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clim.2016.05.003_bb0020","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/S0140-6736(00)05186-2","article-title":"Myasthenia gravis","volume":"357","author":"Vincent","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.clim.2016.05.003_bb0025","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1212\/01.wnl.0000254620.45529.97","article-title":"Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis","volume":"68","author":"Deymeer","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.clim.2016.05.003_bb0030","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/brain\/awg223","article-title":"Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis","volume":"126","author":"Evoli","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.clim.2016.05.003_bb0035","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2016.05.003_bb0040","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ana.22312","article-title":"Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis","volume":"69","author":"Higuchi","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clim.2016.05.003_bb0045","article-title":"Autoantibodies to agrin in myasthenia gravis patients","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2016.05.003_bb0050","first-page":"82","article-title":"Acetylcholine receptor antibody in myasthenia gravis: predominance of IgG subclasses 1 and 3","volume":"67","author":"Rodgaard","year":"1987","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2016.05.003_bb0055","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1056\/NEJM197801192980305","article-title":"Myasthenia gravis (first of two parts)","volume":"298","author":"Drachman","year":"1978","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2016.05.003_bb0060","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1749-6632.1981.tb33730.x","article-title":"The immunopathology of acquired myasthenia gravis","volume":"377","author":"Engel","year":"1981","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.clim.2016.05.003_bb0065","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.autrev.2013.03.001","article-title":"Pathophysiology of myasthenia gravis with antibodies to the acetylcholine receptor, muscle-specific kinase and low-density lipoprotein receptor-related protein 4","volume":"12","author":"Verschuuren","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2016.05.003_bb0070","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.autrev.2013.03.007","article-title":"The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes","volume":"12","author":"Marx","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2016.05.003_bb0075","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF02115001","article-title":"Different HLA DR-DQ associations in subgroups of idiopathic myasthenia gravis","volume":"31","author":"Carlsson","year":"1990","journal-title":"Immunogenetics"},{"key":"10.1016\/j.clim.2016.05.003_bb0080","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/bmj.1.5899.131","article-title":"Myasthenia gravis, autoantibodies, and HL-A antigens","volume":"1","author":"Feltkamp","year":"1974","journal-title":"Br. Med. J."},{"key":"10.1016\/j.clim.2016.05.003_bb0085","doi-asserted-by":"crossref","first-page":"15464","DOI":"10.1073\/pnas.0406756101","article-title":"Pleiotropic effects of the 8.1 HLA haplotype in patients with autoimmune myasthenia gravis and thymus hyperplasia","volume":"101","author":"Vandiedonck","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2016.05.003_bb0090","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.humimm.2004.05.004","article-title":"HLA genotypes in Turkish patients with myasthenia gravis: comparison with multiple sclerosis patients on the basis of clinical subtypes and demographic features","volume":"65","author":"Donmez","year":"2004","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.clim.2016.05.003_bb0095","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1399-0039.1991.tb01851.x","article-title":"Myasthenia gravis patients with thymus hyperplasia and myasthenia gravis patients with thymoma display different HLA associations","volume":"37","author":"Spurkland","year":"1990","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.clim.2016.05.003_bb0100","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0165-5728(93)90021-P","article-title":"Identification by genomic typing of non-DR3 HLA cllas II genes associated with myasthenia gravis","volume":"47","author":"Vieira","year":"1993","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clim.2016.05.003_bb0105","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/08916939508995300","article-title":"Different HLA-DQ are positively and negatively associated in Swedish patients with myasthenia gravis","volume":"22","author":"Hjelmstrom","year":"1995","journal-title":"Autoimmunity"},{"key":"10.1016\/j.clim.2016.05.003_bb0110","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.humimm.2006.02.039","article-title":"HLA-DQ polymorphism in Turkish patients with myasthenia gravis","volume":"67","author":"Saruhan-Direskeneli","year":"2006","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.clim.2016.05.003_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036603","article-title":"Late onset myasthenia gravis is associated with HLA DRB1*15:01 in the Norwegian population","volume":"7","author":"Maniaol","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2016.05.003_bb0120","first-page":"541760","article-title":"Association of HLA-DQB1 *05:02 and DRB1 *16 alleles with late-onset, nonthymomatous, AChR-Ab-positive myasthenia gravis","volume":"2012","author":"Testi","year":"2012","journal-title":"Autoimmun. Dis."},{"key":"10.1016\/j.clim.2016.05.003_bb0125","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1744-313X.2010.00979.x","article-title":"Association with HLA DQ of early onset myasthenia gravis in Southeast Texas region of the United States","volume":"38","author":"Deitiker","year":"2011","journal-title":"Int. J. Immunogenet."},{"key":"10.1016\/j.clim.2016.05.003_bb0130","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jneuroim.2010.10.023","article-title":"Clinical and immunological differences between early and late-onset myasthenia gravis in Japan","volume":"230","author":"Suzuki","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clim.2016.05.003_bb0135","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/acn3.51","article-title":"VAV1 and BAFF, via NFkappaB pathway, are genetic risk factors for myasthenia gravis","volume":"1","author":"Avidan","year":"2014","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.clim.2016.05.003_bb0140","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ana.23691","article-title":"Risk for myasthenia gravis maps to a (151) Pro\u2013>Ala change in TNIP1 and to human leukocyte antigen-B*08","volume":"72","author":"Gregersen","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clim.2016.05.003_bb0145","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1001\/jamaneurol.2014.4103","article-title":"A genome-wide association study of myasthenia gravis","volume":"72","author":"Renton","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.clim.2016.05.003_bb0150","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2119\/molmed.2015.00232","article-title":"Genome-wide association study of late-onset myasthenia gravis: confirmation of TNFRSF11A, and identification of ZBTB10 and three distinct HLA associations","volume":"21","author":"Seldin","year":"2015","journal-title":"Mol. Med."},{"key":"10.1016\/j.clim.2016.05.003_bb0155","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.humimm.2013.08.271","article-title":"Association of HLA-DRB1 *14, -DRB1 *16 and -DQB1 *05 with MuSK-myasthenia gravis in patients from Turkey","volume":"74","author":"Alahgholi-Hajibehzad","year":"2013","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.clim.2016.05.003_bb0160","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1212\/01.wnl.0000339103.08830.86","article-title":"HLA class II allele analysis in MuSK-positive myasthenia gravis suggests a role for DQ5","volume":"72","author":"Bartoccioni","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.clim.2016.05.003_bb0165","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1212\/01.wnl.0000218159.79769.5c","article-title":"Strong association of MuSK antibody-positive myasthenia gravis and HLA-DR14-DQ5","volume":"66","author":"Niks","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.clim.2016.05.003_bb0170","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/ar3204","article-title":"Promise and pitfalls of the Immunochip","volume":"13","author":"Cortes","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clim.2016.05.003_bb0175","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1586\/14737175.9.3.351","article-title":"Autoimmune myasthenia gravis","volume":"9","author":"Gilhus","year":"2009","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.clim.2016.05.003_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000529","article-title":"A flexible and accurate genotype imputation method for the next generation of genome-wide association studies","volume":"5","author":"Howie","year":"2009","journal-title":"PLoS Genet."},{"key":"10.1016\/j.clim.2016.05.003_bb0185","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/ng.2551","article-title":"Identification of multiple independent susceptibility loci in the HLA region in Behcet's disease","volume":"45","author":"Hughes","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.clim.2016.05.003_bb0190","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ajhg.2013.05.026","article-title":"Identification of multiple genetic susceptibility loci in Takayasu arteritis","volume":"93","author":"Saruhan-Direskeneli","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.clim.2016.05.003_bb0195","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/519795","article-title":"PLINK: a tool set for whole-genome association and population-based linkage analyses","volume":"81","author":"Purcell","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.clim.2016.05.003_bb0200","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-2377-10-46","article-title":"A systematic review of population based epidemiological studies in Myasthenia Gravis","volume":"10","author":"Carr","year":"2010","journal-title":"BMC Neurol."},{"key":"10.1016\/j.clim.2016.05.003_bb0205","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0198-8859(99)00062-2","article-title":"A susceptibility region for myasthenia gravis extending into the HLA-class I sector telomeric to HLA-C","volume":"60","author":"Janer","year":"1999","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.clim.2016.05.003_bb0210","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1196\/annals.1254.026","article-title":"Scenarios for autoimmunization of T and B cells in myasthenia gravis","volume":"998","author":"Shiono","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.clim.2016.05.003_bb0215","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jaut.2013.12.004","article-title":"A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis","volume":"52","author":"Zisimopoulou","year":"2014","journal-title":"J. Autoimmun."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661616300766?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661616300766?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T22:55:48Z","timestamp":1536706548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661616300766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":43,"alternative-id":["S1521661616300766"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2016.05.003","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic heterogeneity within the HLA region in three distinct clinical subgroups of myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2016.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}